+91 4162282172 sunil@fopindia.org

Latest News on FOP

Clementia Announces Updated Phase 2 Part B Data on Palovarotene for FOP

Clementia Announces Updated Phase 2 Part B Data on Palovarotene for FOP

Clementia Pharmaceuticals Inc., a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, today announced updated data from the open label extension (“Part B”) of its ongoing Phase 2 clinical trial...

Human skeletal stem cells identified

Human skeletal stem cells identified

Human skeletal stem cells that become bone, cartilage, or stroma cells have been isolated from fetal and adult bones. This is the first time that skeletal stem cells, which had been observed in rodent models, have been identified in humans. The researchers were also...

Regeneron’s LUMINA-1 Trial hosted by FOP Friends

Regeneron’s LUMINA-1 Trial hosted by FOP Friends

Learn more about Regeneron's LUMINA-1 clinical trial presented by Dr. Richard Keen from the Royal National Orthopaedic Hospital in England. This webinar is hosted by FOP Friends in the United Kingdom http://fopfriends.com/. Source: FOPnews